Hong, Simon J. http://orcid.org/0000-0003-3802-1053
Jang, Janice
Berg, Dana
Kirat, Tarik
Remzi, Feza
Chang, Shannon
Malter, Lisa B.
Axelrad, Jordan E.
Hudesman, David P.
Article History
Received: 13 August 2020
Accepted: 25 November 2020
First Online: 21 January 2021
Compliance with Ethical Standards
:
: Simon J. Hong, Janice Jang, Dana R. Berg, Tarik Kirat and Feza Remzi have no disclosures. Shannon Chang has served as a consultant for Pfizer, Shire, and Oshi Health. Lisa B. Malter has received educational or IBD fellowship education grants from AbbVie, Gilead, Janssen Pharmaceuticals, Merck & Co., Inc, Pfizer, Prometheus, Laboratories, Takeda, and UCB. Jordan A. Axelrad has received research support from BioFire Diagnostics and has served as a consultant for BioFire Diagnostics and Janssen Pharmaceuticals. David P. Hudesman has received research support from Pfizer and has served as a consultant for Abbvie, BMS, Janssen, Takeda, Pfizer, and Samsung.
: This study was approved by the Institutional Review Board at NYU Langone Health.